Valeant Readies For More Expansion In 2011
The specialty pharma is gearing up for as many as four more "tuck-in" acquisitions after completing a reverse-merger with Biovail and acquiring PharmaSwiss.
The specialty pharma is gearing up for as many as four more "tuck-in" acquisitions after completing a reverse-merger with Biovail and acquiring PharmaSwiss.